Article
[Efficacy of Haploidentical Hematopoietic Stem Cell Transplantation in Treatment of Intermediate Risk Acute Myeloid Leukemia with Negative for FLT3-ITD, NPM1 or Biallelic CEBPA Mutation].
Zhongguo shi yan xue ye xue za zhi - 1 Jun 2020
Chen Chun, Qi Jia-Qian, Chu Tian-Tian, Wang Hong, Wu De-Pei, Ruan Chang-Geng, Han Yue
Abstract excerpt
OBJECTIVE: To compare the efficacy of haploidentical hematopoietic stem cell transplantation (hi-HSCT) HLA-matched sibling donor hematopoietic stem cell transplantation (MSD-HSCT) and post-remission chemotherapy (PR-CT) in treatment of intermediate risk acute myeloid leukemia with negative for FLT3-ITD, NPM1 or biallelic CEBPA mutation. METHODS: The clinical data of patients with intermediate risk...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.